Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$259.82 - $298.18 $50.4 Million - $57.8 Million
-193,968 Closed
0 $0
Q4 2021

Feb 01, 2022

SELL
$271.6 - $314.21 $706,160 - $816,946
-2,600 Reduced 1.32%
193,968 $60.9 Million
Q2 2021

Aug 10, 2021

BUY
$251.87 - $278.14 $629,675 - $695,350
2,500 Added 1.29%
196,568 $54.2 Million
Q1 2021

May 11, 2021

SELL
$204.88 - $255.03 $6.47 Million - $8.06 Million
-31,600 Reduced 14.0%
194,068 $53.8 Million
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $1.66 Million - $1.91 Million
8,900 Added 4.11%
225,668 $45.9 Million
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $138,968 - $167,481
-832 Reduced 0.38%
216,768 $40.8 Million
Q2 2020

Aug 12, 2020

BUY
$113.31 - $182.44 $566,550 - $912,200
5,000 Added 2.35%
217,600 $36.1 Million
Q1 2020

May 15, 2020

BUY
$104.32 - $195.28 $22.2 Million - $41.5 Million
212,600 New
212,600 $26.9 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Polaris Capital Management, LLC Portfolio

Follow Polaris Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polaris Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polaris Capital Management, LLC with notifications on news.